| Report ID |
130594 |
| Drug Identification Number |
02212218 |
| Brand name |
FORTAZ |
| Common or Proper name |
Ceftazidime |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
CANCELLED POST MARKET |
| Active Ingredient(s) |
CEFTAZIDIME |
| Strength(s) |
1G |
| Dosage form(s) |
POWDER FOR SOLUTION |
| Route of administration |
INTRAMUSCULAR
INTRAVENOUS |
| Packaging size |
All pack sizes / Tous les formats |
| ATC code |
J01DD |
| ATC description |
OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for discontinuation |
Business reasons |
| Anticipated discontinuation date |
|
| Actual discontinuation date |
2020-12-21 |
| Remaining supply date |
2018-09-14 |
| Discontinuation status |
Discontinued |
| Discontinuation decision reversal |
No |
| Information on remaining supply |
|
| Company comments |
|
| Health Canada comments |
|
| Company contact information |
1-800-387-7374 |
